Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TGM2 | P21980 | 8/20 | 0.65 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.50 |
| ▸ | F13A1 | P00488 | 1/20 | 0.49 |
| ▸ | LMNA | P02545 | 1/20 | 0.49 |
| ▸ | TGM1 | P22735 | 1/20 | 0.49 |
| ▸ | TGM3 | Q08188 | 1/20 | 0.49 |
| ▸ | JAK3 | P52333 | 3/20 | 0.48 |
| ▸ | MAP2K7 | O14733 | 2/20 | 0.48 |
| ▸ | EGFR | P00533 | 1/20 | 0.48 |
| ▸ | AURKA | O14965 | 1/20 | 0.48 |
| ▸ | LPAR1 | Q92633 | 1/20 | 0.47 |
| ▸ | LPAR2 | Q9HBW0 | 1/20 | 0.47 |
| ▸ | BTK | Q06187 | 2/20 | 0.47 |
| ▸ | GRIN2D | O15399 | 1/20 | 0.45 |
| ▸ | GRIN3B | O60391 | 1/20 | 0.45 |
| ▸ | GRIN1 | Q05586 | 1/20 | 0.45 |
| ▸ | GRIN2A | Q12879 | 1/20 | 0.45 |
| ▸ | GRIN2B | Q13224 | 1/20 | 0.45 |
| ▸ | GRIN2C | Q14957 | 1/20 | 0.45 |
| ▸ | GRIN3A | Q8TCU5 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4103284 | 0.87 | TGM2 (0.76) | TGM2F13A1LMNATGM1TGM3 | |
| SCHEMBL31043513 | 0.81 | TGM2 (0.53) | TGM2F13A1LMNATGM1TGM3 | |
| SCHEMBL17397388 | 0.80 | TGM2 (0.67) | TGM2F13A1LMNATGM1TGM3 | |
| SCHEMBL29380510 | 0.80 | TGM2 (0.67) | TGM2F13A1LMNATGM1TGM3 | |
| SCHEMBL1119155 | 0.80 | TGM2 (0.67) | TGM2F13A1LMNATGM1TGM3 | |
| SCHEMBL8701998 | 0.79 | SIGMAR1 (0.49) | TGM2TRPV1LMNAGRIN2DGRIN3B | |
| SCHEMBL9838285 | 0.79 | LPAR2 (0.77) | TRPV1LPAR1LPAR2 | |
| SCHEMBL9838293 | 0.79 | LPAR2 (0.77) | TRPV1LPAR1LPAR2 | |
| SCHEMBL7368786 | 0.79 | CYP1A2 (0.64) | TRPV1LPAR1LPAR2GRIN2DGRIN3B | |
| SCHEMBL8572562 | 0.79 | CYP1A2 (0.64) | TRPV1LPAR1LPAR2GRIN2DGRIN3B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4673482-A1 | RADIOPAQUE CROSSLINKED ACRYLAMIDE COPOLYMERS AND USES THEREOF | Boston Scientific Scimed Inc. (US) | 2026-01-07 | — | — | EP | disclosed |
| WO-2024182584-A1 | RADIOPAQUE CROSSLINKED ACRYLAMIDE COPOLYMERS AND USES THEREOF | BOSTON SCIENTIFIC SCIMED, INC. (US) | 2024-09-06 | — | — | WO | disclosed |
| US-20240293583-A1 | RADIOPAQUE CROSSLINKED ACRYLAMIDE COPOLYMERS AND USES THEREOF | BOSTON SCIENTIFIC SCIMED, INC. (US) | 2024-09-05 | — | — | US | disclosed |
| WO-2024050825-A1 | COMPOUNDS AS MLKL INHIBITORS | NATIONAL INSTITUTE OF BIOLOGICAL SCIENCES, BEIJING (CN) | 2024-03-14 | — | — | WO | disclosed |
| US-20220017484-A1 | INHIBITOR OF BRUTON TYROSINE KINASE | BEIJING RECIPROCAPHARMACEUTICALS CO., LTD. (CN) | 2022-01-20 | — | — | US | disclosed |
| WO-2020108619-A1 | MNK INHIBITOR | 上海迪诺医药科技有限公司 | 2020-06-04 | — | — | WO | disclosed |
| WO-2016183094-A1 | BICYCLIC COMPOUNDS | KALYRA PHARMACEUTICALS, INC. (US) | 2016-11-17 | — | — | WO | disclosed |
| EP-2349982-A1 | ACRYLAMIDO DERIVATIVES USEFUL AS INHIBITORS OF THE MITOCHONDRIAL PERMEABILITY TRANSITION | Congenia S.r.l. (IT) | 2011-08-03 | — | — | EP | disclosed |
| WO-2010049768-A1 | ACRYLAMIDO DERIVATIVES USEFUL AS INHIBITORS OF THE MITOCHONDRIAL PERMEABILITY TRANSITION | CONGENIA SRL (IT) | 2010-05-06 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220017484-A1 | INHIBITOR OF BRUTON TYROSINE KINASE | BTK, LYN, SYK | TGM2 1910/4885TRPV1 3686/4885F13A1 566/4885 |
| US-20240293583-A1 | RADIOPAQUE CROSSLINKED ACRYLAMIDE COPOLYMERS AND USES THEREOF | RAD51, TSG101, BRCA1 | TGM2 1994/4885TRPV1 4522/4885F13A1 643/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.